DR Congo: Ebola is killing people before they ever reach a doctor The Bundibugyo strain of Ebola, responsible for a rapidly escalating outbreak in northeastern Democratic Republic of the Congo (DRC), is proving fatal even before patients arrive at medical facilities, according to officials. With no approved vaccine available for this particular variant, the situation remains dire. Three months into the crisis, the World Health Organization (WHO) and Congolese authorities are working to intensify efforts to curb the spread, but challenges persist, particularly in ensuring timely care for those affected. Dr. Mohamed Janabi, WHO Regional Director for Africa, spoke from Bunia, the epicenter of the outbreak in Ituri province, where the virus has claimed hundreds of lives. He described the strain as “outpacing us,” emphasizing the urgency of improving response strategies. His comments came after a recent visit to Bunia, his fifth since the epidemic was officially declared on 15 May. During the trip, he visited several treatment centers and engaged with local leaders to assess why the death toll remains alarmingly high. Discussions revealed critical gaps in the transportation and care systems, with half of the deaths among transported patients attributed to inadequate conditions during transit. The concentration of healthcare resources in Bunia has created a paradox: while the city hosts the primary treatment facilities, the distance between rural communities and these centers means many patients arrive too late for effective intervention. Those who travel long distances often find themselves in severe condition upon arrival, significantly reducing their chances of survival. Moreover, the journey itself poses risks. Patients sometimes bypass direct referral to treatment centers and are instead taken home, leading to increased exposure and potential spread of the virus within their communities. To mitigate these issues, the WHO aims to decentralize healthcare services by establishing treatment facilities closer to affected populations. This strategy includes launching awareness campaigns aimed at educating communities about early symptom recognition and prompt reporting. Additionally, the organization plans to expand bed capacity, adding 400 beds specifically for Ebola patients and 100 for general health services. However, the broader challenge extends beyond medical infrastructure. The WHO stresses the necessity of involving non-health sectors, including local markets and transportation networks, to create a more integrated and responsive system. In a notable development, the town of Aru in Ituri province has demonstrated success through proactive measures. Since detecting the first case, local teams identified 159 contacts, including 121 suspected cases, and expanded monitoring efforts to surrounding communities. By bringing healthcare closer to residents and promoting early intervention, Aru has achieved two weeks of zero new cases, a model that could guide similar initiatives elsewhere. Meanwhile, discussions continue regarding the introduction of vaccines. A clinical trial involving Merck’s Ervebo, designed for the Zaire strain of Ebola, is under consideration for testing against the Bundibugyo variant. Although initial recommendations were hesitant, growing evidence suggests the vaccine might offer some level of cross-protection. The WHO hopes to begin the trial as soon as possible, though questions remain about the availability of sufficient vaccine doses for widespread use. Community engagement has also emerged as a crucial element of the response. Demobilized former rebel fighters in Ituri province are now serving as community mobilizers, promoting hygiene practices and encouraging early reporting of symptoms. Their participation reflects a broader effort to integrate local actors into public health initiatives, fostering trust and cooperation in regions historically marked by conflict. With the outbreak expanding and the risk of transmission increasing, the focus remains on accelerating interventions that prioritize speed, accessibility, and community involvement. The coming weeks will determine whether these strategies can effectively reduce mortality rates and bring the epidemic under control.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter
United States
